Molecular recognition of Docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor α

Journal of Molecular Graphics and Modelling

Volumn 27, Issue 2, 2008, Pages 217-224

  Gani, Osman A B S M ^a   Sylte, Ingebrigt ^a  

^a Faculty of Medicine   (Norway)

Author keywords

Antidiabetic drug; Docking; Docosahexaenoic acid; MD simulations; PPARs

Indexed keywords

ARSENIC COMPOUNDS; BINDING ENERGY; CHEMOTHERAPY; CHLORINE COMPOUNDS; COMPLEXATION; CYTOLOGY; DRUG DELIVERY; DRUG DOSAGE; DYNAMICS; GENES; HEALTH; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NUCLEIC ACIDS; ORGANIC ACIDS; QUANTUM CHEMISTRY;

ANTIDIABETIC; ANTIDIABETIC DRUG; BENEFICIAL EFFECTS; BINDING MODES; COMPUTATIONAL DOCKING; DNA-BINDING; DOCKING; DOCOSAHEXAENOIC ACID; EXPERIMENTAL STUDIES; FISH OIL; HEALTH EFFECTS; HIGH AFFINITY; HIGH AFFINITY BINDING; HYPOLIPIDEMIC DRUGS; MD SIMULATIONS; METABOLIC DISEASES; MOLECULAR DYNAMICS SIMULATION; NATURAL COMPOUNDS; PEROXISOME PROLIFERATOR- ACTIVATED RECEPTOR; PPARS; RETINOID; SIDE EFFECTS; STRUCTURAL EFFECTS;

DRUG INTERACTIONS;

CARBON; DOCOSAHEXAENOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIOGLITAZONE; RETINOID X RECEPTOR ALPHA; ROSIGLITAZONE;

ARTICLE; BINDING AFFINITY; DNA BINDING; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; RECEPTOR BINDING;

COMPUTER SIMULATION; DOCOSAHEXAENOIC ACIDS; HUMANS; HYPOGLYCEMIC AGENTS; LIGANDS; MODELS, MOLECULAR; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROTEIN BINDING; RETINOID X RECEPTOR ALPHA; THERMODYNAMICS; THIAZOLIDINEDIONES;

EID: 52049125233     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2008.04.008     Document Type: Article

References (46)

1. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., Devchand P., Wahli W., Willson T.M., Lenhard J.M., and Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4318-4323
2. Krey G., Braissant O., L'Horset F., Kalkhoven E., Perroud M., Parker M.G., and Wahli W. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11 (1997) 779-791
3. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., and Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2160-2164
4. Willson T.M., Brown P.J., Sternbach D.D., and Henke B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43 (2000) 527-550
5. Nesto R.W., Bell D., Bonow R.O., Fonseca V., Grundy S.M., Horton E.S., Le Winter M., Porte D., Semenkovich C.F., Smith S., Young L.H., and Kahn R. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation 108 October (2003) 2941-2948
6. Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 356 (2007) 2457-2471
7. Fievet C., Fruchart J.C., and Staels B. PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Curr. Opin. Pharmacol. 6 (2006) 606-614
8. Itoh T., Murota I., Yoshikai K., Yamada S., and Yamamoto K. Synthesis of docosahexaenoic acid derivatives designed as novel PPARgamma agonists and antidiabetic agents. Bioorg. Med. Chem. 14 (2006) 98-108
9. Larsen L.N., Granlund L., Holmeide A.K., Skattebol L., Nebb H.I., and Bremer J. Sulfur-substituted and alpha-methylated fatty acids as peroxisome proliferator-activated receptor activators. Lipids 40 (2005) 49-57
10. Fyffe S.A., Alphey M.S., Buetow L., Smith T.K., Ferguson M.A., Sorensen M.D., Bjorkling F., and Hunter W.N. Recombinant human PPAR-beta/delta ligand-binding domain is locked in an activated conformation by endogenous fatty acids. J. Mol. Biol. 356 (2006) 1005-1013
11. Lin Q., Ruuska S.E., Shaw N.S., Dong D., and Noy N. Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry 38 (1999) 185-190
12. Hamilton J.A. Fatty acid transport: difficult or easy?. J. Lipid Res. 39 (1998) 467-481
13. Abagyan R., Totrov M., and Kuznetsov D. Icm - a new method for protein modeling and design - applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 15 (1994) 488-506
14. Nemethy G., Gibson K.D., Palmer K.A., Yoon C.N., Paterlini G., Zagari A., Rumsey S., and Scheraga H.A. Energy parameters in polypeptides. 10: Improved geometrical parameters and nonbonded interactions for use in the Ecepp/3 algorithm, with application to proline-containing peptides. J. Phys. Chem. 96 (1992) 6472-6484
15. Cronet P., Petersen J.F., Folmer R., Blomberg N., Sjoblom K., Karlsson U., Lindstedt E.L., and Bamberg K. Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure (Camb.) 9 (2001) 699-706
16. Egea P.F., Mitschler A., and Moras D. Molecular recognition of agonist ligands by RXRs. Mol. Endocrinol. 16 (2002) 987-997
17. Gampe Jr. R.T., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., and Xu H.E. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 5 (2000) 545-555
18. Halgren T.A. Merck molecular force field. 1: Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 17 (1996) 490-519
19. Schapira M., Totrov M., and Abagyan R. Prediction of the binding energy for small molecules, peptides and proteins. J. Mol. Recognit. 12 (1999) 177-190
20. Makino S., and Kuntz I.D. Automated flexible ligand docking method and its application for database search. J. Comput. Chem. 18 (1997) 1812-1825
21. Wang R., Lai L., and Wang S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J. Comput. Aided Mol. Des. 16 (2002) 11-26
22. Wang R., Liu L., Lai L., and Tang Y. A new empirical method for estimating the binding affinity of a protein-ligand complex. J. Mol. Model. 4 (1998) 379-394
23. Gohlke H., Hendlich M., and Klebe G. Knowledge-based scoring function to predict protein-ligand interactions. J. Mol. Biol. 295 (2000) 337-356
24. Case D.A., Darden T.A., Cheatham III T.E., Simmerling C.L., Wang J., Duke R.E., Luo R., Merz K.M., Wang B., Pearlman D.A., Crowley M., Brozell S., Tsui V., Gohlke H., Mongan J., Hornak V., Cui G., Beroza P., Schafmeister C., Caldwell J.W., Ross W.S., and Kollman P.A. AMBER 8 (2004), University of California, San Francisco, CA
25. Duan Y., Wu C., Chowdhury S., Lee M.C., Xiong G., Zhang W., Yang R., Cieplak P., Luo R., Lee T., Caldwell J., Wang J., and Kollman P. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24 (2003) 1999-2012
26. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Montgomery Jr. J.A., Vreven T., Kudin K.N., Burant J.C., Millam J.M., Iyengar S.S., Tomasi J., Barone V., Mennucci B., Cossi M., Scalmani G., Rega N., Petersson G.A., Nakatsuji H., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Klene M., Li X., Knox J.E., Hratchian H.P., Cross J.B., Bakken V., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J.W., Ayala P.Y., Morokuma K., Voth G.A., Salvador P., Dannenberg J.J., Zakrzewski V.G., Dapprich S., Daniels A.D., Strain M.C., Farkas O., Malick D.K., Rabuck A.D., Raghavachari K., Foresman J.B., Ortiz J.V., Cui Q., Baboul A.G., Clifford S., Cioslowski J., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Martin R.L., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Challacombe M., Gill P.M.W., Johnson B., Chen W., Wong M.W., Gonzalez C., and Pople J.A. Gaussian 03 (2004), Gaussian Inc., Wallingford, CT
27. Cornell W.D., Cieplak P., Bayly C.I., Gould I.R., Merz K.M., Ferguson D.M., Spellmeyer D.C., Fox T., Caldwell J.W., and Kollman P.A. A 2Nd generation force-field for the simulation of proteins, nucleic-acids, and organic-molecules. J. Am. Chem. Soc. 117 (1995) 5179-5197
28. Jorgensen W.L., Chandrasekhar J., Madura J.D., Impey R.W., and Klein M.L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79 (1983) 926-935
29. Ryckaert J.P., Ciccotti G., and Berendsen H.J.C. Numerical-integration of Cartesian equations of motion of a system with constraints-molecular-dynamics of n-alkanes. J. Comput. Phys. 23 (1977) 327-341
30. Juffer A.H., Botta E.F.F., Vankeulen B.A.M., Vanderploeg A., and Berendsen H.J.C. The electric-potential of a macromolecule in a solvent-a fundamental approach. J. Comput. Phys. 97 (1991) 144-171
31. Humphrey W., Dalke A., and Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 14 (1996) 33-38 27-8
32. Aqvist J., and Marelius J. The linear interaction energy method for predicting ligand binding free energies. Comb. Chem. High Throughput Screen 4 (2001) 613-626
33. Hansson T., Marelius J., and Aqvist J. Ligand binding affinity prediction by linear interaction energy methods. J. Comput. Aided Mol. Des. 12 (1998) 27-35
34. Fujimura T., Sakuma H., Ohkubo-Suzuki A., Aramori I., and Mutoh S. Unique properties of coactivator recruitment caused by differential binding of FK614, an anti-diabetic agent, to peroxisome proliferator-activated receptor gamma. Biol. Pharm. Bull. 29 (2006) 423-429
35. Bissantz C., Folkers G., and Rognan D. Protein-based virtual screening of chemical databases. 1: Evaluation of different docking/scoring combinations. J. Med. Chem. 43 (2000) 4759-4767
36. Warren G.L., Andrews C.W., Capelli A.M., Clarke B., LaLonde J., Lambert M.H., Lindvall M., Nevins N., Semus S.F., Senger S., Tedesco G., Wall I.D., Woolven J.M., Peishoff C.E., and Head M.S. A critical assessment of docking programs and scoring functions. J. Med. Chem. 49 (2006) 5912-5931
37. Wang J., Dixon R., and Kollman P.A. Ranking ligand binding affinities with avidin: a molecular dynamics-based interaction energy study. Proteins 34 (1999) 69-81
38. Gani O.A., Adekoya O.A., Giurato L., Spyrakis F., Cozzini P., Guccione S., Winberg J.O., and Sylte I. Theoretical calculations of the catalytic triad in short-chain alcohol dehydrogenases/reductases. Biophys. J. 94 (2008) 1412-1427
39. Parks D.J., Tomkinson N.C., Villeneuve M.S., Blanchard S.G., and Willson T.M. Differential activity of rosiglitazone enantiomers at PPAR gamma. Bioorg. Med. Chem. Lett. 8 (1998) 3657-3658
40. Sohda T., Mizuno K., and Kawamatsu Y. Studies on antidiabetic agents. VI: Asymmetric transformation of (+/-)-5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione(ciglitazone) with optically active 1-phenylethylamines. Chem. Pharm. Bull. (Tokyo) 32 (1984) 4460-4465
41. Barish G.D., Narkar V.A., and Evans R.M. PPAR delta: a dagger in the heart of the metabolic syndrome. J. Clin. Invest. 116 (2006) 590-597
42. Schulman I.G., Shao G., and Heyman R.A. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function. Mol. Cell. Biol. 18 (1998) 3483-3494
43. Shulman A.I., Larson C., Mangelsdorf D.J., and Ranganathan R. Structural determinants of allosteric ligand activation in RXR heterodimers. Cell 116 (2004) 417-429
44. Xu H.E., Lambert M.H., Montana V.G., Plunket K.D., Moore L.B., Collins J.L., Oplinger J.A., Kliewer S.A., Gampe Jr. R.T., McKee D.D., Moore J.T., and Willson T.M. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13919-13924
45. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., and Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395 (1998) 137-143
46. Xu H.E., Lambert M.H., Montana V.G., Parks D.J., Blanchard S.G., Brown P.J., Sternbach D.D., Lehmann J.M., Wisely G.B., Willson T.M., Kliewer S.A., and Milburn M.V. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell 3 (1999) 397-403